Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P43250
UPID:
GRK6_HUMAN
Alternative names:
G protein-coupled receptor kinase GRK6
Alternative UPACC:
P43250; O60541; Q13652
Background:
G protein-coupled receptor kinase 6 (GRK6) plays a pivotal role in cellular signaling by specifically phosphorylating activated forms of G protein-coupled receptors. This action triggers beta-arrestin-mediated receptor desensitization, internalization, and subsequent signaling events. GRK6 is instrumental in the desensitization of D2-like dopamine receptors in the striatum and the chemokine receptor CXCR4, essential for CXCL12-induced cell chemotaxis. Additionally, it phosphorylates rhodopsin and LRP6 during Wnt signaling.
Therapeutic significance:
Understanding the role of G protein-coupled receptor kinase 6 could open doors to potential therapeutic strategies.